WeVote
Log In

Bill

Bill

HB 1197

Anaphylaxis in Public Schools

2025 Regular Session Introduced by Jessica Baker and 6 co-sponsors

Florida schools must stock epinephrine auto-injectors and train staff to administer them during anaphylactic emergencies to improve student survival rates.

Laid on Table, companion bill(s) passed, see CS/CS/SB 1514 (Ch. 2025-47)
#k
0
WeVote Research Nonpartisan
Bill Summary · HB 1197

Legislative bill overview

HB 1197 requires Florida public schools to stock and maintain epinephrine auto-injectors (EpiPens) in accessible locations and train staff to administer them during anaphylactic emergencies. The bill establishes protocols for storage, staff training, and documentation of anaphylaxis incidents in schools.

Why is this important

Anaphylaxis is a life-threatening allergic reaction that can occur in schools without warning, and delays in epinephrine administration significantly reduce survival rates. Currently, schools may lack readily available epinephrine or trained personnel, leaving students vulnerable. This bill ensures faster emergency response and potentially saves lives by standardizing preparedness across all public schools.

Potential points of contention

  • Liability and training burden: Schools must invest in staff training and maintain certification, raising questions about who bears costs and liability if administration errors occur
  • Funding requirements: The bill mandates supplies and training but may not provide adequate state funding, potentially shifting costs to already-stretched school budgets
  • Over-prescription concerns: Some stakeholders worry about unnecessary epinephrine use or whether schools should be primary responders rather than emergency medical personnel
  • Storage and accessibility: Balancing easy staff access against preventing unauthorized student access to medications requires careful implementation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.